Edward N Brody

Title: Innovations of Edward N Brody

Introduction

Edward N Brody is a notable inventor based in Boulder, CO, who has made significant contributions to the fields of cardiovascular health and oncology. With a total of two patents to his name, Brody's work focuses on the prediction and diagnosis of critical health conditions.

Latest Patents

Brody's latest patents include "Cardiovascular risk event prediction and uses thereof" and "Lung cancer biomarkers and uses thereof." The first patent provides methods and computer methods to assess an individual's risk of developing a cardiovascular event over a 1 to 5 year period. This innovative approach employs at least two biomarkers, such as MMP12, angiopoietin-2, and cardiac troponin I, among others, to predict cardiovascular events, particularly in patients suffering from coronary heart disease. The second patent addresses lung cancer detection, offering biomarkers, methods, devices, and kits for diagnosing lung cancer. This application allows for the differential diagnosis of pulmonary nodules as benign or malignant, enhancing early detection and treatment options.

Career Highlights

Throughout his career, Edward N Brody has worked with prominent companies, including Somalogic, Incorporated and Somalogic Operating Co., Inc. His expertise in biomarker research has positioned him as a leader in the development of diagnostic methods that can significantly impact patient outcomes.

Collaborations

Brody has collaborated with notable professionals in his field, including Larry M Gold and Marty Stanton. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Edward N Brody's innovative work in cardiovascular risk prediction and lung cancer diagnosis exemplifies the impact of research and invention on healthcare. His contributions continue to pave the way for advancements in medical diagnostics and patient care.